Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/18207
Title: | Human Wharton's jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis. | Authors: | DONDERS, Raf VANHEUSDEN, Marjan BOGIE, Jeroen RAVANIDIS, Stelios THEWISSEN, Kristof STINISSEN, Piet GYSELAERS, Wilfried HENDRIKS, Jerome HELLINGS, Niels |
Issue Date: | 2014 | Source: | CELL TRANSPLANTATION, 24 (10), p. 2077-2098 | Abstract: | Umbilical cord matrix or Wharton?s jelly-derived stromal cells (WJ-MSCs) are an easily accessible source of mesenchymal-like stem cells. Recent studies describe a hypo-immunogenic phenotype, multipotent differentiation potential and trophic support function for WJ-MSCs, with variable clinical benefit in degenerative disease models such as stroke, myocardial infarction and Parkinson?s disease. It remains unclear whether WJ-MSCs have therapeutic value for multiple sclerosis (MS), where autoimmune-mediated demyelination and neurodegeneration need to be halted. In this study, we investigated whether WJ-MSCs possess the required properties to effectively and durably reverse these pathological hallmarks, and whether they survive in an inflammatory environment after transplantation. WJ-MSCs displayed a lowly immunogenic phenotype and showed intrinsic expression of neurotrophic factors and a variety of anti-inflammatory molecules. Furthermore, they dose-dependently suppressed proliferation of activated T cells using contact-dependent and paracrine mechanisms. Indoleamine 2,3-dioxygenase 1 was identified as one of the main effector molecules responsible for the observed T cell suppression. The immune-modulatory phenotype of WJ-MSCs was further enhanced after pro-inflammatory cytokine treatment in vitro (licensing). In addition to their effect on adaptive immunity, WJ-MSCs interfered with dendritic cell differentiation and maturation, thus directly affecting antigen presentation and therefore T cell priming. Systemically infused WJ-MSCs potently but transiently ameliorated experimental autoimmune encephalomyelitis (EAE), an animal model for MS, when injected at onset or during chronic disease. This protective effect was paralleled with a reduction in autoantigen-induced T cell proliferation, confirming their immune-modulatory activity in vivo. Surprisingly, in vitro licensed WJ-MSCs did not ameliorate EAE, indicative of a fast rejection as a result of enhanced immunogenicity. Collectively, we show that WJ-MSCs have trophic support properties and effectively modulate immune cell functioning both in vitro and in the EAE model, suggesting WJ-MSC may hold promise for MS therapy. Future research is needed to optimize survival of stem cells and enhance clinical durability. | Notes: | Hellings, N (reprint author), Hasselt Univ, Biomed Res Inst, Campus Diepenbeek,Agoralaan Bldg C, B-3590 Diepenbeek, Belgium. niels.hellings@uhasselt.be | Keywords: | cell therapy; immunomodulation; mesenchymal stem cells (MSCs); Multiple Sclerosis; transplantation; Wharton’s jelly | Document URI: | http://hdl.handle.net/1942/18207 | ISSN: | 0963-6897 | e-ISSN: | 1555-3892 | DOI: | 10.3727/096368914X685104 | ISI #: | 000362861200013 | Rights: | Copyright © 2014 Cognizant Communication Corporation | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2016 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ct-1266_donders_et_al_1412946660552.pdf Restricted Access | Peer-reviewed author version | 1.55 MB | Adobe PDF | View/Open Request a copy |
096368914x685104.pdf | Published version | 1.64 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
42
checked on Sep 5, 2020
WEB OF SCIENCETM
Citations
62
checked on Oct 13, 2024
Page view(s)
84
checked on Aug 31, 2022
Download(s)
158
checked on Aug 31, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.